Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
780
-
Total shares
-
66.2M
-
Shares change
-
-825K
-
Total reported value, excl. options
-
$21.8B
-
Value change
-
-$238M
-
Put/Call ratio
-
0.89
-
Number of buys
-
353
-
Number of sells
-
-340
-
Price
-
$330.16
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2020
794 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2020.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 780 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.2M shares
of 80.8M outstanding shares and own 81.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.42M shares), Fundsmith LLP (4.24M shares), STATE STREET CORP (3.74M shares), BAMCO INC /NY/ (3.44M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.52M shares), BLAIR WILLIAM & CO/IL (1.55M shares), GEODE CAPITAL MANAGEMENT, LLC (1.39M shares), ALLIANCEBERNSTEIN L.P. (1.31M shares), PRINCIPAL FINANCIAL GROUP INC (1.24M shares), and AMERICAN CENTURY COMPANIES INC (1.2M shares).
This table shows the top 780 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.